(Q34499122)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400459%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Metformin does not improve survival in patients with hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400459%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400459%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

8

Gregory J Gores

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400459%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

4

Cathy D Schleck

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400459%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

William Scott Harmsen

3

object named as

William S Harmsen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400459%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Mamatha Bhat

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400459%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Roongruedee Chaiteerakij

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400459%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Ju Dong Yang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400459%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Nasra H Giama

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400459%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Terry M Therneau

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400459%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

English

0 references

publication date

1 November 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400459%20AND%20SRC:MED&resulttype=core&format=json

World Journal of Gastroenterology

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400459%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400459%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400459%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

15750-15755

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400459%20AND%20SRC:MED&resulttype=core&format=json

Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo

22 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229540

Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229540

Association between metformin therapy and mortality after breast cancer: a population-based study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229540

Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229540

Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229540

Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229540

The insulin and insulin-like growth factor receptor family in neoplasia: an update

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229540

Metformin inhibits melanoma development through autophagy and apoptosis mechanisms.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229540

Phase 1/2 study of everolimus in advanced hepatocellular carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229540

Metformin prevents tobacco carcinogen--induced lung tumorigenesis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229540

Diabetes and cancer: a consensus report.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229540

Pivotal role of mTOR signaling in hepatocellular carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229540

Sorafenib in advanced hepatocellular carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229540

Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229540

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229540

Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229540

Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229540

Hepatocellular carcinoma: recent trends in the United States

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229540

Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229540

Liver disease and diabetes mellitus.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229540

Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo.

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.3748%2FWJG.V20.I42.15750

Demographic and clinico-pathological characteristics in patients with invasive breast cancer receiving metformin.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.3748%2FWJG.V20.I42.15750

In vitro and in vivo antitumoral action of metformin on hepatocellular carcinoma

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229540

Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229540

Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229540

10.3748/WJG.V20.I42.15750

27 October 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400459%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400459%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400459%20AND%20SRC:MED&resulttype=core&format=json